Cancer fund has led to 'devastating divide' in treatment

clock

The Cancer Drugs Fund has led to a ‘devastating divide' in access to treatment between England and other home nations, according to a cancer charity.

Equal funding could be achieved across the nation at an extra cost of £1 per person per year for residents of Wales and England who are not able to access the fund, the Rarer Cancers Foundation (RCF) added. It found that people in Wales were five times less likely to get access to a newer cancer drug on the NHS than those in England, while those in Scotland were three times less likely. If funding and access levels were the same nationwide, it would benefit 159 more patients a year in Wales and 248 in Scotland. The charity's Nation Divided? report took aim at both the Scottish and ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on PMI

PMI

Bupa rolls out full mental health cover to individual market

Time limits removed

Adam Saville
clock 07 June 2019 • 1 min read
PMI

VitalityHealth launches 'comprehensive' mental health package

Unlimited CBT and counselling

Adam Saville
clock 07 February 2019 • 2 min read
PMI

April UK withdraws from UK health insurance market

'Existing PMI customers will require advice'

Adam Saville
clock 19 July 2018 • 1 min read